Dean D. T. Maglinte

University of Indianapolis

Papers

1

Total Citations

19

H-Index

1

About

Dr. Dean D. T. Maglinte is a pioneering gynecologic oncologist whose work focuses on fertility-sparing surgical innovations for advanced cervical cancer. His most cited study, a 2012 case report, demonstrates a groundbreaking approach to stage IB2 cervical cancer by combining neoadjuvant chemotherapy with simultaneous robotic-assisted radical trachelectomy and tubal sterilization reversal. This dual procedure, cited 19 times, represents a significant contribution to oncologic fertility preservation, offering women with advanced disease the possibility of retaining reproductive function without compromising oncologic outcomes. Dr. Maglinte’s work sits at the intersection of minimally invasive robotic surgery, neoadjuvant treatment protocols, and reproductive medicine, showcasing a holistic approach to cancer care. His research has influenced clinical strategies for managing bulky cervical tumors, particularly in young patients desiring future fertility. By integrating chemotherapy response assessment with precise surgical techniques, he has helped expand the boundaries of what is achievable in gynecologic oncology, making him a notable figure in the field of fertility-sparing cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Chemotherapy Followed by Simultaneous Robotic Radical Trachelectomy and Reversal of Tubal Sterilization in Stage IB2 Cervical Cancer
19 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Indianapolis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago